AR030430A1 - Procedimiento para la obtencion de quimicos finos por cultivo de organismos que presentan una via de shiquimato modificada, composicion de acido nucleinico, uso de dicho acido nucleinico para la obtencion de plantas transgenicas, organismo geneticamente modificado, procedimiento para la produccion d - Google Patents
Procedimiento para la obtencion de quimicos finos por cultivo de organismos que presentan una via de shiquimato modificada, composicion de acido nucleinico, uso de dicho acido nucleinico para la obtencion de plantas transgenicas, organismo geneticamente modificado, procedimiento para la produccion dInfo
- Publication number
- AR030430A1 AR030430A1 ARP010103057A ARP010103057A AR030430A1 AR 030430 A1 AR030430 A1 AR 030430A1 AR P010103057 A ARP010103057 A AR P010103057A AR P010103057 A ARP010103057 A AR P010103057A AR 030430 A1 AR030430 A1 AR 030430A1
- Authority
- AR
- Argentina
- Prior art keywords
- pathway
- obtaining
- organism
- procedure
- nucleinic
- Prior art date
Links
- 239000002253 acid Substances 0.000 title abstract 5
- 239000012847 fine chemical Substances 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 4
- 230000009261 transgenic effect Effects 0.000 title 1
- 230000037361 pathway Effects 0.000 abstract 6
- 108020004707 nucleic acids Proteins 0.000 abstract 4
- 150000007523 nucleic acids Chemical class 0.000 abstract 4
- 102000039446 nucleic acids Human genes 0.000 abstract 4
- 108090000623 proteins and genes Proteins 0.000 abstract 4
- 102000004190 Enzymes Human genes 0.000 abstract 3
- 108090000790 Enzymes Proteins 0.000 abstract 3
- 150000001413 amino acids Chemical class 0.000 abstract 3
- 235000003869 genetically modified organism Nutrition 0.000 abstract 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 2
- 230000002255 enzymatic effect Effects 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 abstract 1
- 229930003427 Vitamin E Natural products 0.000 abstract 1
- 229930003448 Vitamin K Natural products 0.000 abstract 1
- 150000007513 acids Chemical class 0.000 abstract 1
- 230000004913 activation Effects 0.000 abstract 1
- 235000017471 coenzyme Q10 Nutrition 0.000 abstract 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 abstract 1
- 238000012258 culturing Methods 0.000 abstract 1
- 238000012217 deletion Methods 0.000 abstract 1
- 230000037430 deletion Effects 0.000 abstract 1
- 235000013305 food Nutrition 0.000 abstract 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 abstract 1
- 238000012239 gene modification Methods 0.000 abstract 1
- 230000005017 genetic modification Effects 0.000 abstract 1
- 235000013617 genetically modified food Nutrition 0.000 abstract 1
- 238000010348 incorporation Methods 0.000 abstract 1
- 238000003780 insertion Methods 0.000 abstract 1
- 230000037431 insertion Effects 0.000 abstract 1
- 230000037353 metabolic pathway Effects 0.000 abstract 1
- 239000002207 metabolite Substances 0.000 abstract 1
- 230000002018 overexpression Effects 0.000 abstract 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 abstract 1
- 230000008569 process Effects 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 abstract 1
- 235000021067 refined food Nutrition 0.000 abstract 1
- 238000006467 substitution reaction Methods 0.000 abstract 1
- 230000007704 transition Effects 0.000 abstract 1
- 229940035936 ubiquinone Drugs 0.000 abstract 1
- 235000019165 vitamin E Nutrition 0.000 abstract 1
- 229940046009 vitamin E Drugs 0.000 abstract 1
- 239000011709 vitamin E Substances 0.000 abstract 1
- 235000019168 vitamin K Nutrition 0.000 abstract 1
- 239000011712 vitamin K Substances 0.000 abstract 1
- 150000003721 vitamin K derivatives Chemical class 0.000 abstract 1
- 229940046010 vitamin k Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/001—Oxidoreductases (1.) acting on the CH-CH group of donors (1.3)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/90—Isomerases (5.)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Abstract
Procedimiento para la obtencion de químicos finos por cultivo de organismos, tales como plantas, que presentan una vía de shiquimato, modificada en comparacion con el tipo silvestre, por alteracion de la actividad de al menos una enzima de la vía de shiquimato se selecciona por lo menos una medida del grupo de las medidas A y B, teniendo A y B los significados siguientes: A: aumento de la activacion de por lo menos una enzima de la vía de shiquimato del tipo silvestre; B: incorporacion de por lo menos un gen en el organismo frente al que el tipo silvestre no presente ningun gen ortologico y que puentea la ruta metabolica de la vía de shiquimato. Preferentemente, en la medida A, se aumenta la actividad de por lo menos una enzima de la vía de shiquimato por sobreexpresion de ácidos nucleínicos, que codifican para proteínas con esta actividad enzimática. Más preferentemente, el ácido nucleico codifica una corismato-mutasa en el organismo. Composicion de ácido nucleico, que contiene un ácido nucleico codificante para un péptido de transicion plastídico y un ácido nucleico, que codifica para una proteína que contiene la secuencia e aminoácido SEQ ID No. 4 o una secuencia derivada de la misma por sustitucion, insercion o delecion de aminoácidos, que presenta una homología de por lo menos un 30% a nivel de aminoácido con la secuencia SEQ ID No. 4 y la propiedad enzimática de una corismato-mutasa. Organismo genéticamente modificado, siendo preciso que la modificacion genética cambia el flujo de metabolito de la vía de shiquimato, en comparacion con el tipo silvestre, y que el organismo presenta un contenido modificado en químicos finos, en comparacion con el tipo silvestre, tales como la vitamina E, vitamina K y/o ubiquinona. Procedimiento para la produccion de dichos organismos genéticamente modificados en donde se incorpora por lo menos un ácido nucleínico o por lo menos una composicion de ácido nucleínico segun lo descripto en el genoma del organismo de partida. Uso de los organismos genéticamente modificados para la produccion de químicos finos, o como alimento humano o animal, o para la obtencion de alimentos procesados.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2000130647 DE10030647A1 (de) | 2000-06-29 | 2000-06-29 | Veränderung des Gehalts an Feinchemikalien in Organismen durch genetische Veränderung des Shikimatweges |
DE2000164454 DE10064454A1 (de) | 2000-12-21 | 2000-12-21 | Veränderung des Gehalts an Feinchemikalien in Organismen durch genetische Veränderung des Shikimatweges |
Publications (1)
Publication Number | Publication Date |
---|---|
AR030430A1 true AR030430A1 (es) | 2003-08-20 |
Family
ID=26006169
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP010103057A AR030430A1 (es) | 2000-06-29 | 2001-06-27 | Procedimiento para la obtencion de quimicos finos por cultivo de organismos que presentan una via de shiquimato modificada, composicion de acido nucleinico, uso de dicho acido nucleinico para la obtencion de plantas transgenicas, organismo geneticamente modificado, procedimiento para la produccion d |
Country Status (13)
Country | Link |
---|---|
US (1) | US7332649B2 (es) |
EP (1) | EP1294913B1 (es) |
JP (1) | JP2004501649A (es) |
CN (1) | CN1439054A (es) |
AR (1) | AR030430A1 (es) |
AT (1) | ATE389025T1 (es) |
AU (1) | AU2001266096A1 (es) |
BR (1) | BR0112052A (es) |
CA (1) | CA2413049A1 (es) |
CZ (1) | CZ20024144A3 (es) |
DE (1) | DE50113727D1 (es) |
PL (1) | PL360365A1 (es) |
WO (1) | WO2002000901A1 (es) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0009763B8 (pt) | 1999-04-15 | 2020-03-10 | Calgene Llc | sequência de ácido nucléico codificando uma preniltransferase, construção compreendendo a mesma, bem como métodos para alteração do teor de tocoferol, produção de um composto de tocoferol,e aumento do fluxo biossintético em uma célula |
US6872815B1 (en) | 2000-10-14 | 2005-03-29 | Calgene Llc | Nucleic acid sequences to proteins involved in tocopherol synthesis |
EP1356033B1 (en) | 2000-08-07 | 2009-10-28 | Monsanto Technology LLC | Methyl-d-erythritol phosphate pathway genes |
FR2817557B1 (fr) * | 2000-12-05 | 2005-05-06 | Aventis Cropscience Sa | Nouvelles cibles pour herbicides et plantes transgeniques resistantes a ces herbicides |
AU2007249135B2 (en) * | 2000-12-05 | 2010-03-04 | Bayer S.A.S. | Novel targets for herbicides and transgenic plants resistant to said herbicides |
EP1950305A1 (en) * | 2001-05-09 | 2008-07-30 | Monsanto Technology, LLC | Tyr a genes and uses thereof |
ATE419366T1 (de) * | 2001-05-09 | 2009-01-15 | Monsanto Technology Llc | Tyra-gene und ihre verwendung |
AU2002329759A1 (en) | 2001-08-17 | 2003-03-03 | Monsanto Technology Llc | Methyltransferase genes and uses thereof |
DE10212703A1 (de) * | 2002-03-21 | 2003-10-02 | Sungene Gmbh & Co Kgaa | Erhöhung Vitamin-E-Gehalts in Organismen durch Erhöhung der 2-Methyl-6-phytythydrochinon-Methyltransferase-Aktivität |
DE10231587A1 (de) * | 2002-07-11 | 2004-01-29 | Sungene Gmbh & Co. Kgaa | Transgene Expressionskonstrukte und Verfahren zum Erhöhen des Vitamin E-Gehaltes in pflanzlichen Organismen |
DE10232483A1 (de) * | 2002-07-17 | 2004-02-05 | Sungene Gmbh & Co. Kgaa | Transgene Expressionskonstrukte und Verfahren zum Erhöhen des Vitamin E-Gehaltes in pflanzlichen Organismen |
FR2844142B1 (fr) * | 2002-09-11 | 2007-08-17 | Bayer Cropscience Sa | Plantes transformees a biosynthese de prenylquinones amelioree |
US20110179523A1 (en) * | 2008-09-30 | 2011-07-21 | Basf Plant Science Gmbh | Method for Producing a Transgenic Plant Cell, a Plant or a Part Thereof with Increased Resistance Biotic Stress |
AU2010209874A1 (en) * | 2009-01-28 | 2011-08-18 | Basf Plant Science Company Gmbh | Transgenic plants having altered nitrogen metabolism |
CN113061619B (zh) * | 2021-04-30 | 2022-06-24 | 中国烟草总公司郑州烟草研究院 | 与烟气苯酚释放量相关的突变基因TyrA |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4956282A (en) * | 1985-07-29 | 1990-09-11 | Calgene, Inc. | Mammalian peptide expression in plant cells |
JPS63105688A (ja) * | 1986-10-21 | 1988-05-10 | Kyowa Hakko Kogyo Co Ltd | L−フエニルアラニンの製造法 |
JP2578488B2 (ja) * | 1988-03-04 | 1997-02-05 | 協和醗酵工業株式会社 | アミノ酸の製造法 |
US5120837A (en) * | 1989-09-20 | 1992-06-09 | The Nutrasweet Company | Dna encoding phe a feedback inhibition resistant enzyme analogues |
US6087563A (en) | 1996-01-29 | 2000-07-11 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Cloned arabidopsis p-hydroxyphenyl pyruvic acid dioxygenase DNA |
US6642434B1 (en) | 1997-07-25 | 2003-11-04 | University Of Community College System Of Nevada | Transgenic plants with γ-tocopherol methyltransferase |
DE19752647C1 (de) | 1997-10-29 | 1999-06-24 | Inst Pflanzengenetik & Kultur | Reduktiion des Chlorophyllgehaltes in Ölpflanzensamen |
AU757440B2 (en) * | 1998-08-05 | 2003-02-20 | Sungene Gmbh And Co. Kgaa | DNA sequence coding for a 1-deoxy-d-xylulose-5-phosphate synthase and the overproduction thereof in plants |
-
2001
- 2001-06-27 AR ARP010103057A patent/AR030430A1/es not_active Application Discontinuation
- 2001-06-28 PL PL36036501A patent/PL360365A1/xx not_active Application Discontinuation
- 2001-06-28 DE DE50113727T patent/DE50113727D1/de not_active Expired - Lifetime
- 2001-06-28 AT AT01943549T patent/ATE389025T1/de not_active IP Right Cessation
- 2001-06-28 AU AU2001266096A patent/AU2001266096A1/en not_active Abandoned
- 2001-06-28 CZ CZ20024144A patent/CZ20024144A3/cs unknown
- 2001-06-28 US US10/297,661 patent/US7332649B2/en not_active Expired - Fee Related
- 2001-06-28 EP EP01943549A patent/EP1294913B1/de not_active Expired - Lifetime
- 2001-06-28 WO PCT/EP2001/007391 patent/WO2002000901A1/de active IP Right Grant
- 2001-06-28 CN CN01811927A patent/CN1439054A/zh active Pending
- 2001-06-28 CA CA002413049A patent/CA2413049A1/en not_active Abandoned
- 2001-06-28 JP JP2002506216A patent/JP2004501649A/ja active Pending
- 2001-06-28 BR BR0112052-2A patent/BR0112052A/pt not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
US20060057687A1 (en) | 2006-03-16 |
PL360365A1 (en) | 2004-09-06 |
CN1439054A (zh) | 2003-08-27 |
BR0112052A (pt) | 2004-02-10 |
AU2001266096A1 (en) | 2002-01-08 |
US7332649B2 (en) | 2008-02-19 |
JP2004501649A (ja) | 2004-01-22 |
ATE389025T1 (de) | 2008-03-15 |
CZ20024144A3 (cs) | 2003-05-14 |
DE50113727D1 (de) | 2008-04-24 |
WO2002000901A1 (de) | 2002-01-03 |
EP1294913A1 (de) | 2003-03-26 |
EP1294913B1 (de) | 2008-03-12 |
CA2413049A1 (en) | 2002-01-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR030430A1 (es) | Procedimiento para la obtencion de quimicos finos por cultivo de organismos que presentan una via de shiquimato modificada, composicion de acido nucleinico, uso de dicho acido nucleinico para la obtencion de plantas transgenicas, organismo geneticamente modificado, procedimiento para la produccion d | |
ES2368221T3 (es) | Producción recombinante de agentes antimicrobianos. | |
CN1816564B (zh) | 能选择性杀伤癌细胞的RasGAP衍生肽 | |
DE69738804D1 (de) | Blütenorgan-spezifische promotersequenzen | |
EP1712625A4 (en) | TRANSCRIPTION FACTOR ARABIDOPIS THALIANA, GENE ENCODING THE SAME AND USE THEREOF | |
WO2019004878A1 (ru) | Препарат цистеиновой протеиназы пшеницы тритикаина-альфа, полученной в растворимой форме, и способ получения препарата | |
WO2012154024A1 (en) | Cis-prenyl transferase from the plant hevea brasiliensis | |
CN1798838B (zh) | 一种蛋白酶的抑制剂蛋白及其用途 | |
CN104119445A (zh) | 含有富含亮氨酸重复序列的融合蛋白及其制法和应用 | |
AU2007208928A8 (en) | Transgenic plant transformed with stress-responsive gene | |
CN107075501A (zh) | 炎症报道系统 | |
CN100390286C (zh) | 新酶基因及其表达产物 | |
JP5641477B2 (ja) | Nell−1による組織・臓器異所再生制御技術 | |
CN109628460A (zh) | 一种超深渊来源抗菌肽hydramacin及其制备方法 | |
ES2632431T3 (es) | Moléculas de neurturina mejoradas | |
CN104119448A (zh) | 含有富含亮氨酸重复序列的融合蛋白及其制法和应用 | |
CN109517814A (zh) | 有机磷降解酶的突变体及其应用 | |
CN104119447A (zh) | 含有富含亮氨酸重复序列的融合蛋白及其制法和应用 | |
US20230287059A1 (en) | A molecular strategy to protect against desiccation | |
Tao et al. | Expression of apalbumin1 of Apis cerana cerana in the larvae of silkworm, Bombyx mori | |
CN107922463A (zh) | 具有提高的光合能力的微生物 | |
JPH05178896A (ja) | 新規なタンパク質、それをコードする遺伝子及びその産生方法 | |
CN101851627A (zh) | 中华绒螯蟹半胱氨酸蛋白酶抑制剂EsCystatin基因编码蛋白及应用 | |
KR101860902B1 (ko) | 남극 요각류 티그리오푸스 킹세종엔시스 유래의 스테아로일-CoA 불포화효소 및 이의 용도 | |
KR101687903B1 (ko) | 멧누에 유래 특이적 Dpp 유전자 및 그 유전자의 발현 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |